Chemed Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 365.69 M

Chemed Corporation Operating Cash Flow is USD 365.69 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.20% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Chemed Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 354.36 M, a 31.59% change year over year.
  • Chemed Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 269.29 M, a -11.12% change year over year.
  • Chemed Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 302.97 M, a -40.21% change year over year.
  • Chemed Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 506.68 M, a 59.84% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities